ATA 2018 Satellite Symposium
| Browse by: | Sort by: |
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
ATA Satellite Symposium Welcome Remarks
Charles H. Emerson, MD
University of Massachusetts School of Medicine, Worchester, Massachusetts
Available
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Program Overview
Manisha H. Shah, MD
The Ohio State University, Columbus, Ohio
Available
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Defining the Spectrum of Differentiated Thyroid Cancer: A Clinical Perspective
Lilah F. Morris-Wiseman, MD
Banner University Medical Center, Tucson , Arizona
Available
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Defining the Spectrum of Differentiated Thyroid Cancer: A Histological and Molecular Perspective
Thomas J. Giordano , MD, PhD
University of Michigan, Ann Arbor, Michigan
Available
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Active Surveillance in Differentiated Thyroid Cancer
Wendy Sacks, MD
Cedars-Sinai Medical Center, Los Angeles, California
Available
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Challenging the Minimalist Approach to Surgical Intervention in Differentiated Thyroid Cancer
Ralph P. Tufano, MD, MBA, FACS
Johns Hopkins University School of Medicine, Baltimore, Maryland
Challenging the Minimalist Approach to Surgical Intervention in Differentiated Thyroid Cancer
Mona M. Sabra, MD
Memorial Sloan-Kettering Cancer Center, New York, New York
Challenging the Minimalist Approach to Surgical Intervention in Differentiated Thyroid Cancer
Carmen C. Solórzano, MD, FACS
Vanderbilt University, Nashville, Tennessee
Available
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Controversies in Radioactive Iodine Adjuvant Therapy: Which patients? How much to give?
Stephanie L. Lee, MD, PhD
Boston University Medical Center, Boston, Massachusetts
Available
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Controversies in Radioactive Iodine Adjuvant Therapy: Which patients? How much to give?
David S. Cooper, MD, MACP
Johns Hopkins University School of Medicine, Baltimore, Maryland
Available
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Controversies in Radioactive Iodine Adjuvant Therapy: Which patients? How much to give?
Kenneth D. Burman, MD
MedStar Washington Hospital Center, Washington, DC
Available
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Systemic Therapy Options: Standard of Care and Beyond for Advanced Differentiated Thyroid Cancer
Manisha H. Shah, MD
The Ohio State University, Columbus, Ohio
Available
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Insights and Surprises from an Online Survey of Thyroid Cancer Patients
Elizabeth Gardner Grubbs, MD, MS, FACS
The University of Texas M. D. Anderson Cancer Center, Houston, Texas
Insights and Surprises from an Online Survey of Thyroid Cancer Patients
Mara Y. Roth, MD
University of Washington, Seattle, Washington
Free
Slides + audio
ATA 2018 Satellite Symposium: The Spectrum of Thyroid Cancer, from Surveillance to Systemic Therapy
Questions and Answers
Manisha H. Shah, MD
The Ohio State University, Columbus, Ohio
Free
Slides + audio
